ArticleOncotarget2016

Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics.

Philip R Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.